Yihe Biotech

Tianjin Yihe Biotechnology Co., Ltd. (Yihe Biotech) is a pioneering synthetic biology company established in 2023 that specializes in the large-scale biomanufacturing of healthy rare sugars. The company utilizes a disruptive in vitro synthetic biology platform based on multi-enzyme molecular machines, a technology exclusively licensed from the Tianjin Institute of Industrial Biotechnology (TIB) of the Chinese Academy of Sciences. By converting low-cost starch feedstocks into high-value functional sugars such as D-tagatose, D-allulose, and D-mannose, Yihe Biotech addresses global health challenges like diabetes and obesity through innovative nutrition and metabolic health solutions. Its proprietary biomanufacturing process offers a more sustainable, efficient, and cost-effective alternative to traditional fermentation and chemical synthesis methods.